Dr Robert Zeman Receives Thorwarth Award for Radiology Leadership

Dr Robert Zeman: The American College of Radiology® (ACR®) Economics and Health Policy Department today announced Robert Zeman, MD, FACR, FSAR, as the 2022 recipient of the William T. Thorwarth Jr., MD, Award at ACR 2022®, the College’s annual meeting in Washington, DC.

This honor recognizes individuals who demonstrate outstanding contributions to the field of health policy and economics for radiology. Dr. Zeman is a Professor and Chairman of Radiology and Radiation Oncology at the George Washington University School of Medicine.

“Dr Robert Zeman’s contributions within the ACR, specifically his commitment to the Contractor Advisory Committee Network, as well as his involvement at the Centers for Medicare and Medicaid Services (CMS) and other organizations, has helped amplify the voice of radiology,” said Gregory Nicola, MD, FACR, Chair of the ACR Commission on Economics. “He continues to give back by educating future generations of radiologists and I am honored to present him with this prestigious award.”

Dr Robert Zeman is receiving the award for 17 years of dedicated service in various capacities on the ACR Commission on Economics, including Chair of the Contractor Advisory Committee Network. He was an integral voice in national and local Medicare coverage determinations for many imaging services, including computed tomography, magnetic resonance imaging and positron emission tomography policies. Dr. Zeman served as a voting member of the CMS Medicare Evidence Development and Coverage Advisory Committee Panel for four years.

The William T. Thorwarth Jr., MD, Award was established in 2004 by the ACR Commission on Economics to honor members or staff who show excellence in the field of economics and health policy by way of leadership, diplomacy and integrity.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”